探路者(300005.SZ):合作研發的下肢外骨骼產品採用基於人因功效學的仿生結構設計
格隆匯5月14日丨探路者(300005.SZ)在投資者互動平臺表示,公司合作研發的下肢外骨骼產品採用基於人因功效學的仿生結構設計,集成多模態傳感器系統和智能化運動控制算法最終實現人機交互智能識別,能夠自主識別用戶的行走、上下臺階、上山下坡等各種人體運動狀態,並根據不同的動作模式自動切換助力模式,在確保用戶安全的情況下,提供穩定、舒適的助力體驗,主要應用在戶外徒步、登山、探險等高強度運動,以及老年等特殊人羣運動能力增強等領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.